Case Report
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. May 27, 2024; 16(5): 1449-1460
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1449
Figure 3
Figure 3 Kaplan-Meier survival curve of the 45 neuroendocrine carcinomas of the extrahepatic bile duct patients with survival follow-up data. A: The median overall survival was 12 months; B: Kaplan-Meier survival curves of extrahepatic bile duct patients with neuroendocrine-non-neuroendocrine neoplasm and pure neuroendocrine carcinoma were compared and log-rank test were assessed for significance (P = 0.20). MiNEN: Mixed neuroendocrine-non-neuroendocrine neoplasm; EBNEC: Extrahepatic bile duct patients with neuroendocrine-non-neuroendocrine neoplasm; NEC: Neuroendocrine carcinoma.